24/7 Patient Assistance: 760-405-8205

Mack Roach, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information

    Dr. Mack Roach is a recognized radiation oncologist in San Francisco, California. He received his medical diploma from Stanford University School of Medicine in 1979. Dr. Roach completed his medical education with 3 residencies: one residency in internal medicine at King Drew Medical Center, a second residency in internal medicine at Alameda County Medical Center, a third residency in radiation oncology at Stanford University and a fellowship in hematology at UCSF. He is certified by the American Board in medical oncology, internal medicine, and radiation oncology. His subspecialty is urologic cancer. This doctor is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center, UCSF Medical Center and San Francisco Veterans Affairs Medical Center. He was awarded 16 honors, including ASCO Fellow in 2010. He has published a huge number of articles in cooperation with other doctors. He is a fellow member of the American Society of Clinical Oncology.



  • Education & Training

    dept_icon

    Stanford University

    Medical School

    dept_icon

    King Drew Medical Center

    Residency

    dept_icon

    UCSF

    Fellowship

    dept_icon

    Alameda County Medical Center

    Residency

    dept_icon

    Stanford University

    Residency

  • Board Certifications

    American Board of Radiology - Diagnostic Radiology

  • Hospital & Practice

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Mack Roach has contributed to 3 publications.

    Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate Cancer.

    Roach, M.; J. Urol.. 2016 May 11.

    See more >>

    An Evaluation of Robotic and Conventional IMRT for Prostate Cancer: Potential for Dose Escalation.

    Pinnaduwage, D. S.,Descovich, M.,Lometti, M. W.,Varad, B.,Roach, M.,Gottschalk, A. R.; Technol. Cancer Res. Treat.. 1900 Jan 01.

    See more >>

    Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.

    Chan, J.,Roach, M.; Eur. Urol.. 2016 Feb 13.

    See more >>